GlassScriptPhysician profile
Julie Winn
NPI 1891203493
$2,225.45
in general payments reported to CMS, 2019-2025
14 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $78.79 · 2023: $1,544 · 2024: $189 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,237 · Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,237.28 |
| Food and Beverage | $790.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $964.64 | 2023 | |
| Arthrex, INC. | $442.48 | 2023 | |
| Bioventus LLC | $158.34 | 2022-2025 | Durolane |
| Vertex Pharmaceuticals Incorporated | $152.58 | 2025 | |
| Smith+Nephew, INC. | $137.24 | 2023 | N/A |
| Ferring Pharmaceuticals INC. | $131.95 | 2024-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $68.30 | 2021-2024 | Orthovisc, Monovisc |
| Heron Therapeutics, INC. | $43.17 | 2021 | |
| Endo USA, INC. | $26.40 | 2025 | Xiaflex |
| Pacira Therapeutics, INC. | $23.34 | 2021 | |
| Integra Lifesciences Corporation | $23.09 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.65 | 2021 | |
| Convatec INC. | $18.80 | 2024 | |
| Fidia Pharma USA INC. | $14.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Winn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.